FEATURED
During ACLC 2022, Dr. Noemi Reguart reviewed the data for MET-targeting TKIs and monoclonal antibodies for patients with METex14 skipping mutations, MET amplification, and MET overexpression. Read more
LATEST NEWS
Prof. Denis Horgan, executive director for the European Alliance for Personalised Medicine, writes that while the intentions behind the EU’s new cancer screening recommendations ar... Read more
In Part 2 of our series on non-traditional methods to help patients quit smoking, Dr. Deepti Behl says it is important for healthcare providers to encourage their patients to quit... Read more
While the harmful effects of smoking are well known, the negative impacts of continued smoking after a cancer diagnosis are underappreciated. With Lung Cancer Awareness Month under... Read more